Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

PAXIL CR

GLAXOSMITHKLINE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of PAXIL CR in Canada?

A shortage of PAXIL CR 12.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated July 24, 2026), but it has not started yet.

Why is PAXIL CR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will PAXIL CR be available again?

The manufacturer's estimated resolution date is December 18, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Guide

Why Psychiatric Medications Keep Going Into Shortage in Canada

Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~3 months remaining (estimate)
Affected strength12.5MG
Last updated2026-07-24

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

APO-PAROXETINE

APOTEX INC

30MG · DIN 02240909

Different strengthDifferent dosage formSame routeNo current shortage

DOM-PAROXETINE

DOMINION PHARMACAL

30MG · DIN 02248449

Different strengthDifferent dosage formSame routeNo current shortage

PRO-PAROXETINE

PRO DOC LIMITEE

20MG · DIN 02248914

Different strengthDifferent dosage formSame routeNo current shortage

RATIO-PAROXETINE

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

30MG · DIN 02247812

Different strengthDifferent dosage formSame routeNo current shortage

PAROXETINE

MELIAPHARM INC

20MG · DIN 02248451

Different strengthDifferent dosage formSame routeNo current shortage

SANDOZ PAROXETINE

SANDOZ CANADA INCORPORATED

20MG · DIN 02254751

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02248503

Strength

12.5MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

PAROXETINE

See all PAROXETINE products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History